Inventor

POZNANSKY MARK C

US31 patents

⚠️ This page may combine multiple inventors who share the name “POZNANSKY MARK C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

POZNANSKY MARK C

MASSACHUSETTS GEN HOSPITAL

HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease

Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer

HSP fusion protein with anti-chemorepellant agent for treatment of cancer

Antigen-binding fusion proteins with modified HSP70 domains

HSP fusion protein with anti-chemorepellant agent for treatment of cancer

Localized delivery of anti-fugetactic agent for treatment of cancer

Modified natural killer cells for the treatment of cancer

Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer

Antifugetactic agents for the treatment of cancers

CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease

Eluting matrix and uses thereof

Eluting matrix and uses thereof

Eluting matrix and uses thereof

Coxiella burnetii epitopes for T cell-targeted Q fever vaccines

Immunotherapies employing self-assembling vaccines

Method of treating cervical neoplasia in patients infected with human papilloma virus

Methods for detecting and treating cancer

GEN HOSPITAL CORP

Purposeful movement of human migratory cells away from an agent source

Purposeful movement of human migratory cells away from an agent source

Purposeful movement of human migratory cells away from an agent source

Fugetactic proteins, compositions and methods of use

CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis

POZNANSKY MARK C

Anti-fugetactic agents for the treatment of ovarian cancer

Cell therapy for limiting overzealous inflammatory reactions in tissue healing

Recovery of tissue function following administration of B cells to injured tissue

Methods for detecting and treating cancer

CYTOMATRIX LLC

Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices

(unassigned)

Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices

ACTX INC

Recovery of tissue function following administration of B cells to injured tissue

BRIGHAM & WOMENS HOSPITAL

CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis

GELFAND JEFFREY A

Immunotherapies employing self-assembling vaccines